The introduction of triptans, in the early 1990s, has improved the therapy for acute migraine attack, offering a new quality of life for those patients who suffer from this disabling neurological disorder. Epidemiological data point out that about 10% of school–age children suffer from migraine, with a progressive increase in incidence and prevalence up to the threshold of adulthood. The increase in extent and prevalence of migraine from the years of growth stresses the importance of the application and adjustment of ad hoc therapeutic (either pharmacological or not) and diagnostic measures. Indeed, the peculiar neurobiological and psychological aspects which are typical of an “evolving” organism preclude the use, by simple “transposition” or “proportion”, of the knowledge acquired from adult–targeted studies. That requires the implementation of studies to analyze the specific responses of children and adolescents to the triptans. To date, the studies on such issues are absolutely insufficient to draw definitive conclusions and indications for the use of triptans for child and adolescent migraineurs.

Up to date on the use of triptans for child and adolescent migraine: “the state of the art” / D., Calderoni; Galli, Federica; Guidetti, Vincenzo. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - 2:(2001), pp. s97-s103.

Up to date on the use of triptans for child and adolescent migraine: “the state of the art”

GALLI, FEDERICA;GUIDETTI, Vincenzo
2001

Abstract

The introduction of triptans, in the early 1990s, has improved the therapy for acute migraine attack, offering a new quality of life for those patients who suffer from this disabling neurological disorder. Epidemiological data point out that about 10% of school–age children suffer from migraine, with a progressive increase in incidence and prevalence up to the threshold of adulthood. The increase in extent and prevalence of migraine from the years of growth stresses the importance of the application and adjustment of ad hoc therapeutic (either pharmacological or not) and diagnostic measures. Indeed, the peculiar neurobiological and psychological aspects which are typical of an “evolving” organism preclude the use, by simple “transposition” or “proportion”, of the knowledge acquired from adult–targeted studies. That requires the implementation of studies to analyze the specific responses of children and adolescents to the triptans. To date, the studies on such issues are absolutely insufficient to draw definitive conclusions and indications for the use of triptans for child and adolescent migraineurs.
2001
migraine; triptans, child; adolescent; acute therapy
01 Pubblicazione su rivista::01a Articolo in rivista
Up to date on the use of triptans for child and adolescent migraine: “the state of the art” / D., Calderoni; Galli, Federica; Guidetti, Vincenzo. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - 2:(2001), pp. s97-s103.
File allegati a questo prodotto
File Dimensione Formato  
Calderoni_Up-to-date_2001.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 43.37 kB
Formato Adobe PDF
43.37 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/363782
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact